<unk>  Immediate Release is indicated for the relief of moderate to severe pain, such as treatment of acute post surgical pain. For any chronic treatment of pain, clinicians should only consider long term use if there is significant clinical benefit to the patient's therapy that outweigh any potential risk. The first line treatment choices for chronic pain are non-pharmacological and non-opioid agents.<unk>  extended-release tablets are indicated for the management of chronic pain and only for people already on a regular schedule of strong opioids for a prolonged period. Immediate-release<unk>  tablets are recommended for breakthrough pain for people on the extended-release version. Compared to other opioids,<unk>  has similar pain relieving efficacy. In the United States it is a Schedule II controlled substance with an ACSCN of 9652.<unk>  ER Tablets should be taken on an empty stomach.
Oxymorphone
Hydromorphone
Oxymorphol
Butorphanol
Morphine
Noroxycodone
Nalorphine
Oxycodone